APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Biologics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17404598032 January 2026191 pages

Choose your research edition.

Industry ResearchVeterinary Biologics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Biologics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Veterinary Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Biologics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Biologics Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Veterinary Biologics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Biologics include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Biologics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Biologics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Biologics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Biologics market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Biologics Segment by Company

Avimex Animal

Bio-Labs

Boehringer Ingelheim

CAHIC

CAVAC

Ceva

DHN

Elanco/Eli Lilly

FATRO

HVRI

Kyoto Biken

Ringpu Biology

Vaksindo

Virbac

WINSUN

Yebio

Zoetis

ChengDu Tecbond

Jinyu Bio-Technology

Merck

Veterinary Biologics Segment by Type

Vaccines

Monoclonal Antibodies

Veterinary Biologics Segment by Application

Llivestock

Equine

Other

Veterinary Biologics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Biologics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Biologics Industry Trends Table 2. Veterinary Biologics Industry Drivers Table 3. Veterinary Biologics Industry Opportunities and Challenges Table 4. Veterinary Biologics Industry Restraints Table 5. Global Veterinary Biologics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Biologics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Biologics Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Veterinary Biologics Sales Market Share by Manufacturers Table 9. Global Veterinary Biologics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Biologics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Biologics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Biologics Manufacturers, Product Type & Application Table 13. Global Veterinary Biologics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Biologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vaccines Table 17. Major Manufacturers of Monoclonal Antibodies Table 18. Global Veterinary Biologics Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Veterinary Biologics Sales by Type (2021-2026) & (M Units) Table 20. Global Veterinary Biologics Sales by Type (2027-2032) & (M Units) Table 21. Global Veterinary Biologics Sales Market Share by Type (2021-2026) Table 22. Global Veterinary Biologics Sales Market Share by Type (2027-2032) Table 23. Global Veterinary Biologics Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Veterinary Biologics Revenue by Type (2021-2026) & (M Units) Table 25. Global Veterinary Biologics Revenue by Type (2027-2032) & (M Units) Table 26. Global Veterinary Biologics Revenue Market Share by Type (2021-2026) Table 27. Global Veterinary Biologics Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Llivestock Table 29. Major Manufacturers of Equine Table 30. Major Manufacturers of Other Table 31. Global Veterinary Biologics Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Veterinary Biologics Sales by Application (2021-2026) & (M Units) Table 33. Global Veterinary Biologics Sales by Application (2027-2032) & (M Units) Table 34. Global Veterinary Biologics Sales Market Share by Application (2021-2026) Table 35. Global Veterinary Biologics Sales Market Share by Application (2027-2032) Table 36. Global Veterinary Biologics Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Veterinary Biologics Revenue by Application (2021-2026) & (M Units) Table 38. Global Veterinary Biologics Revenue by Application (2027-2032) & (M Units) Table 39. Global Veterinary Biologics Revenue Market Share by Application (2021-2026) Table 40. Global Veterinary Biologics Revenue Market Share by Application (2027-2032) Table 41. Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Veterinary Biologics Sales by Region (2021-2026) & (M Units) Table 43. Global Veterinary Biologics Sales Market Share by Region (2021-2026) Table 44. Global Veterinary Biologics Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Veterinary Biologics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 48. North America Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 49. Europe Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 51. Europe Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 58. Global Veterinary Biologics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Biologics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Veterinary Biologics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Veterinary Biologics Revenue Market Share by Region (2021-2026) Table 62. Global Veterinary Biologics Revenue Market Share by Region (2027-2032) Table 63. Avimex Animal Company Information Table 64. Avimex Animal Business Overview Table 65. Avimex Animal Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Avimex Animal Veterinary Biologics Product Portfolio Table 67. Avimex Animal Recent Development Table 68. Bio-Labs Company Information Table 69. Bio-Labs Business Overview Table 70. Bio-Labs Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bio-Labs Veterinary Biologics Product Portfolio Table 72. Bio-Labs Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Veterinary Biologics Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. CAHIC Company Information Table 79. CAHIC Business Overview Table 80. CAHIC Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CAHIC Veterinary Biologics Product Portfolio Table 82. CAHIC Recent Development Table 83. CAVAC Company Information Table 84. CAVAC Business Overview Table 85. CAVAC Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CAVAC Veterinary Biologics Product Portfolio Table 87. CAVAC Recent Development Table 88. Ceva Company Information Table 89. Ceva Business Overview Table 90. Ceva Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ceva Veterinary Biologics Product Portfolio Table 92. Ceva Recent Development Table 93. DHN Company Information Table 94. DHN Business Overview Table 95. DHN Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. DHN Veterinary Biologics Product Portfolio Table 97. DHN Recent Development Table 98. Elanco/Eli Lilly Company Information Table 99. Elanco/Eli Lilly Business Overview Table 100. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Elanco/Eli Lilly Veterinary Biologics Product Portfolio Table 102. Elanco/Eli Lilly Recent Development Table 103. FATRO Company Information Table 104. FATRO Business Overview Table 105. FATRO Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. FATRO Veterinary Biologics Product Portfolio Table 107. FATRO Recent Development Table 108. HVRI Company Information Table 109. HVRI Business Overview Table 110. HVRI Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. HVRI Veterinary Biologics Product Portfolio Table 112. HVRI Recent Development Table 113. Kyoto Biken Company Information Table 114. Kyoto Biken Business Overview Table 115. Kyoto Biken Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Kyoto Biken Veterinary Biologics Product Portfolio Table 117. Kyoto Biken Recent Development Table 118. Ringpu Biology Company Information Table 119. Ringpu Biology Business Overview Table 120. Ringpu Biology Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Ringpu Biology Veterinary Biologics Product Portfolio Table 122. Ringpu Biology Recent Development Table 123. Vaksindo Company Information Table 124. Vaksindo Business Overview Table 125. Vaksindo Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Vaksindo Veterinary Biologics Product Portfolio Table 127. Vaksindo Recent Development Table 128. Virbac Company Information Table 129. Virbac Business Overview Table 130. Virbac Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Virbac Veterinary Biologics Product Portfolio Table 132. Virbac Recent Development Table 133. WINSUN Company Information Table 134. WINSUN Business Overview Table 135. WINSUN Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. WINSUN Veterinary Biologics Product Portfolio Table 137. WINSUN Recent Development Table 138. Yebio Company Information Table 139. Yebio Business Overview Table 140. Yebio Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Yebio Veterinary Biologics Product Portfolio Table 142. Yebio Recent Development Table 143. Zoetis Company Information Table 144. Zoetis Business Overview Table 145. Zoetis Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Zoetis Veterinary Biologics Product Portfolio Table 147. Zoetis Recent Development Table 148. ChengDu Tecbond Company Information Table 149. ChengDu Tecbond Business Overview Table 150. ChengDu Tecbond Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. ChengDu Tecbond Veterinary Biologics Product Portfolio Table 152. ChengDu Tecbond Recent Development Table 153. Jinyu Bio-Technology Company Information Table 154. Jinyu Bio-Technology Business Overview Table 155. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Jinyu Bio-Technology Veterinary Biologics Product Portfolio Table 157. Jinyu Bio-Technology Recent Development Table 158. Merck Company Information Table 159. Merck Business Overview Table 160. Merck Veterinary Biologics Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Merck Veterinary Biologics Product Portfolio Table 162. Merck Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Veterinary Biologics Distributors List Table 166. Veterinary Biologics Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Veterinary Biologics Product Image Figure 2. Global Veterinary Biologics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Biologics Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Biologics Sales (2021-2032) & (M Units) Figure 5. Global Veterinary Biologics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Biologics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vaccines Image Figure 9. Monoclonal Antibodies Image Figure 10. Global Veterinary Biologics Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Veterinary Biologics Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Biologics Sales Market Share by Type (2021-2032) Figure 13. Global Veterinary Biologics Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Veterinary Biologics Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Biologics Revenue Market Share by Type (2021-2032) Figure 16. Llivestock Image Figure 17. Equine Image Figure 18. Other Image Figure 19. Global Veterinary Biologics Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Veterinary Biologics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Biologics Sales Market Share by Application (2021-2032) Figure 22. Global Veterinary Biologics Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Veterinary Biologics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Biologics Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Veterinary Biologics Sales Market Share by Country (2021-2032) Figure 27. U.S. Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Veterinary Biologics Sales Market Share by Country (2021-2032) Figure 32. Germany Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Veterinary Biologics Sales Market Share by Country (2021-2032) Figure 39. China Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Veterinary Biologics Sales Market Share by Country (2021-2032) Figure 47. Brazil Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Veterinary Biologics Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Veterinary Biologics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Veterinary Biologics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Veterinary Biologics Revenue (2021-2032) & (US$ Million) Figure 58. North America Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Biologics Revenue (2021-2032) & (US$ Million) Figure 60. Europe Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Biologics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Veterinary Biologics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Veterinary Biologics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Veterinary Biologics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Monoclonal Antibodies
Applications
  • Llivestock
  • Equine
  • Other
Companies covered
  • Avimex Animal
  • Bio-Labs
  • Boehringer Ingelheim
  • CAHIC
  • CAVAC
  • Ceva
  • DHN
  • Elanco/Eli Lilly
  • FATRO
  • HVRI
  • Kyoto Biken
  • Ringpu Biology
  • Vaksindo
  • Virbac
  • WINSUN
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Jinyu Bio-Technology
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Biologics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Biologics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Biologics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Biologics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Biologics Market Dynamics
  1. 2.1 Veterinary Biologics Industry Trends
  2. 2.2 Veterinary Biologics Industry Drivers
  3. 2.3 Veterinary Biologics Industry Opportunities and Challenges
  4. 2.4 Veterinary Biologics Industry Restraints
3 Veterinary Biologics Market by Manufacturers
  1. 3.1 Global Veterinary Biologics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Biologics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Biologics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Biologics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Biologics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Biologics Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Biologics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Biologics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Biologics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Biologics Tier 1, Tier 2, and Tier 3
4 Veterinary Biologics Market by Type
  1. 4.1 Veterinary Biologics Type Introduction
  2. 4.1.1 Vaccines
  3. 4.1.2 Monoclonal Antibodies
  4. 4.2 Global Veterinary Biologics Sales by Type
  5. 4.2.1 Global Veterinary Biologics Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Biologics Sales by Type (2021-2032)
  7. 4.2.3 Global Veterinary Biologics Sales Market Share by Type (2021-2032)
  8. 4.3 Global Veterinary Biologics Revenue by Type
  9. 4.3.1 Global Veterinary Biologics Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Biologics Revenue by Type (2021-2032)
  11. 4.3.3 Global Veterinary Biologics Revenue Market Share by Type (2021-2032)
5 Veterinary Biologics Market by Application
  1. 5.1 Veterinary Biologics Application Introduction
  2. 5.1.1 Llivestock
  3. 5.1.2 Equine
  4. 5.1.3 Other
  5. 5.2 Global Veterinary Biologics Sales by Application
  6. 5.2.1 Global Veterinary Biologics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Biologics Sales by Application (2021-2032)
  8. 5.2.3 Global Veterinary Biologics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Veterinary Biologics Revenue by Application
  10. 5.3.1 Global Veterinary Biologics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Biologics Revenue by Application (2021-2032)
  12. 5.3.3 Global Veterinary Biologics Revenue Market Share by Application (2021-2032)
6 Global Veterinary Biologics Sales by Region
  1. 6.1 Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Biologics Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Biologics Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Biologics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Biologics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Biologics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Biologics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Biologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Biologics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Biologics Revenue by Region
  1. 7.1 Global Veterinary Biologics Revenue by Region
  2. 7.1.1 Global Veterinary Biologics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Biologics Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Biologics Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Biologics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Biologics Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Biologics Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Biologics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Biologics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Biologics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Avimex Animal
  2. 8.1.1 Avimex Animal Company Information
  3. 8.1.2 Avimex Animal Business Overview
  4. 8.1.3 Avimex Animal Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Avimex Animal Veterinary Biologics Product Portfolio
  6. 8.1.5 Avimex Animal Recent Developments
  7. 8.2 Bio-Labs
  8. 8.2.1 Bio-Labs Company Information
  9. 8.2.2 Bio-Labs Business Overview
  10. 8.2.3 Bio-Labs Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio-Labs Veterinary Biologics Product Portfolio
  12. 8.2.5 Bio-Labs Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 CAHIC
  20. 8.4.1 CAHIC Company Information
  21. 8.4.2 CAHIC Business Overview
  22. 8.4.3 CAHIC Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CAHIC Veterinary Biologics Product Portfolio
  24. 8.4.5 CAHIC Recent Developments
  25. 8.5 CAVAC
  26. 8.5.1 CAVAC Company Information
  27. 8.5.2 CAVAC Business Overview
  28. 8.5.3 CAVAC Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CAVAC Veterinary Biologics Product Portfolio
  30. 8.5.5 CAVAC Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Veterinary Biologics Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 DHN
  38. 8.7.1 DHN Company Information
  39. 8.7.2 DHN Business Overview
  40. 8.7.3 DHN Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DHN Veterinary Biologics Product Portfolio
  42. 8.7.5 DHN Recent Developments
  43. 8.8 Elanco/Eli Lilly
  44. 8.8.1 Elanco/Eli Lilly Company Information
  45. 8.8.2 Elanco/Eli Lilly Business Overview
  46. 8.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
  48. 8.8.5 Elanco/Eli Lilly Recent Developments
  49. 8.9 FATRO
  50. 8.9.1 FATRO Company Information
  51. 8.9.2 FATRO Business Overview
  52. 8.9.3 FATRO Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FATRO Veterinary Biologics Product Portfolio
  54. 8.9.5 FATRO Recent Developments
  55. 8.10 HVRI
  56. 8.10.1 HVRI Company Information
  57. 8.10.2 HVRI Business Overview
  58. 8.10.3 HVRI Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HVRI Veterinary Biologics Product Portfolio
  60. 8.10.5 HVRI Recent Developments
  61. 8.11 Kyoto Biken
  62. 8.11.1 Kyoto Biken Company Information
  63. 8.11.2 Kyoto Biken Business Overview
  64. 8.11.3 Kyoto Biken Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
  66. 8.11.5 Kyoto Biken Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Vaksindo
  74. 8.13.1 Vaksindo Company Information
  75. 8.13.2 Vaksindo Business Overview
  76. 8.13.3 Vaksindo Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vaksindo Veterinary Biologics Product Portfolio
  78. 8.13.5 Vaksindo Recent Developments
  79. 8.14 Virbac
  80. 8.14.1 Virbac Company Information
  81. 8.14.2 Virbac Business Overview
  82. 8.14.3 Virbac Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Virbac Veterinary Biologics Product Portfolio
  84. 8.14.5 Virbac Recent Developments
  85. 8.15 WINSUN
  86. 8.15.1 WINSUN Company Information
  87. 8.15.2 WINSUN Business Overview
  88. 8.15.3 WINSUN Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 WINSUN Veterinary Biologics Product Portfolio
  90. 8.15.5 WINSUN Recent Developments
  91. 8.16 Yebio
  92. 8.16.1 Yebio Company Information
  93. 8.16.2 Yebio Business Overview
  94. 8.16.3 Yebio Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Yebio Veterinary Biologics Product Portfolio
  96. 8.16.5 Yebio Recent Developments
  97. 8.17 Zoetis
  98. 8.17.1 Zoetis Company Information
  99. 8.17.2 Zoetis Business Overview
  100. 8.17.3 Zoetis Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zoetis Veterinary Biologics Product Portfolio
  102. 8.17.5 Zoetis Recent Developments
  103. 8.18 ChengDu Tecbond
  104. 8.18.1 ChengDu Tecbond Company Information
  105. 8.18.2 ChengDu Tecbond Business Overview
  106. 8.18.3 ChengDu Tecbond Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
  108. 8.18.5 ChengDu Tecbond Recent Developments
  109. 8.19 Jinyu Bio-Technology
  110. 8.19.1 Jinyu Bio-Technology Company Information
  111. 8.19.2 Jinyu Bio-Technology Business Overview
  112. 8.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
  114. 8.19.5 Jinyu Bio-Technology Recent Developments
  115. 8.20 Merck
  116. 8.20.1 Merck Company Information
  117. 8.20.2 Merck Business Overview
  118. 8.20.3 Merck Veterinary Biologics Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Merck Veterinary Biologics Product Portfolio
  120. 8.20.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Biologics Value Chain Analysis
  2. 9.1.1 Veterinary Biologics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Biologics Production Mode & Process
  6. 9.2 Veterinary Biologics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Biologics Distributors
  9. 9.2.3 Veterinary Biologics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst